Searching for New Partners

Sapience Therapeutics is seeking partners for discovery, licensing, and co-development opportunities.

For inquiries and further information, please contact:

Barry Kappel, Ph.D., MBA

Discovering Novel Drug Candidates

Our PADS platform enables discovery peptide-antagonists to targets of our choosing entities.

Learn About Our Platforms

A Robust Pipeline for Undruggable Targets

The drugs in our pipeline are designed to disrupt specific protein-protein interactions, which allows the targeting of intracellular proteins previously viewed as undruggable.

View Our Pipeline